Company News
AstraZeneca Shares Jump 6% After Merger Denial
AstraZeneca stock rose about 6% on Wednesday after a senior source confirmed no merger talks with Bristol Myers Squibb.
The denial reversed a roughly 9% one‑day drop on Monday, which had been the FTSE
